beta
/Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE/EGFR to reduce inflammation and epithelial dysfunction
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)